1) partially HLA-unmatched HSCT
HLA配型部分相合造血干细胞移植
2) hematopoietic stem cell ransplantation
配型不合造血干细胞移植
4) ABO-incompatible allogeneic stem cell transplantation
ABO血型不合造血干细胞移植
1.
Objective To study pure red cell aplasia(PRCA) of complication after ABO- incompatible allogeneic stem cell transplantation.
结论免疫因素及a抗体是ABO血型不合造血干细胞移植后致PRCA的最可能原因;糖皮质激素(泼尼松)是治疗ABO血型不合造血干细胞移植后PRCA的有效、经济、安全的药物。
5) Mixed-HSCT
混合造血干细胞移植
1.
The clinical study of using DLI+IL-2 after Mixed-HSCT in acute myelogenous leukemia;
DLI+IL-2后续治疗混合造血干细胞移植后的急性髓性白血病
6) haploidentical hematopoietic stem cell transplantation
单倍体相合造血干细胞移植
1.
The aim of this study was to evaluate the impact of donor killer cell immunoglobulin-like receptor(KIR)and recipient HLA genotypes on outcome following haploidentical hematopoietic stem cell transplantation(HSCT).
本研究探讨供者杀伤细胞免疫球蛋白样受体(KIR)和受者人类白细胞抗原(HLA)基因型在单倍体相合造血干细胞移植(HSCT)预后中的意义。
2.
To investigate the characteristics and significance of reconstitution of peripheral blood plasmacytoid dendritic cell (PDC) precursors after allogeneic human leukocyte antigen mismatched/ haploidentical hematopoietic stem cell transplantation, and its relationship with chronic graft versus host disease(cGVHD)and relapse, 19 patients with leukemia were enrolled for this study.
为了探讨浆样树突状细胞(PDC)在单倍体相合造血干细胞移植术后重建的特点及其与慢性移植物抗宿主病(cGVHD)和患者复发的关系,采用流式细胞术对19例白血病患者移植后外周血树突状细胞(DC)亚群晚期重建进行动态监测,并将其与患者cGVHD和复发的关系进行分析。
补充资料：配干
1.犹配天。谓功德与天相比匹。干，指天。 2.谓匹配于夫。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条